Correction to: Nature Communications https://doi.org/10.1038/s41467-024-50354-5, published online 24 July 2024
In this article Figure 1 was an older version, which does not match the figure legend and duplicates panels from Figure 2. The updated and correct Figure 1 is below.
Data has not changed, and no text was amended. The original article has been corrected.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Tribble, J.R., Jöe, M., Varricchio, C. et al. Author Correction: NMNAT2 is a druggable target to drive neuronal NAD production. Nat Commun 15, 8143 (2024). https://doi.org/10.1038/s41467-024-52439-7
Published:
DOI: https://doi.org/10.1038/s41467-024-52439-7
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
